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Consumption of functional foods for lowering serum cholesterol has globally gained acceptance by the general public. Turtle
jelly (TJ), also called gui-ling-gao, is a popular traditional functional food in southern China. The hypocholesterolemic eﬀect
of consuming TJ was investigated in rats fed with normal diet, high-cholesterol diet or high-cholesterol diet supplemented
with simvastatin (3mg/kg bw per day, p.o.) or TJ (3.3 or 10mL/kg bw per day, p.o.) for 30 days. TJ markedly reversed
the increased serum total cholesterol, increased high-density lipoprotein, and decreased high-density lipoprotein induced
by hypercholesterolemic diet with a dose-dependent improvement on the atherogenic index. It also demonstrated good
hepatoprotective function by reducing fat depositions and overall lipid contents in the liver and increasing the activities of hepatic
antioxidative enzymes. The blunted nitric oxide/endothelium-mediated aortic relaxation in rats fed with hypercholesterolemic
diet was partially restored after TJ consumption. It is postulated that the hypocholesterolemic eﬀect is the primary beneficial eﬀect
given by TJ; it then leads to secondary beneficial eﬀects such as vasoprotective and hepatoprotective functions. The results revealed
that TJ could block the downregulation of LDLR and PEPCK and upregulation of PPARα mRNA and protein expressions in the
livers of rats fed with hypercholesterolemic diet.
1. Introduction
Hypercholesterolemia is a dominant risk factor for the
development and progression of atherosclerosis and is closely
related to cardiovascular diseases (CVD) [1]. The modern
lifestyle of high-cholesterol diet and inadequate physical
activity contributes to hypercholesterolemia which increases
the prevalence of CVD. Diet high in cholesterol is a major
environmental contributor to the metabolic disturbance
of lipoprotein which is closely tied to atherosclerosis, a
leading cause of death in the developed countries. It is
generally believed that reduction of total cholesterol and low-
density lipoprotein cholesterol (LDL) reduces atherosclerosis
in animals and clinical cardiovascular events in humans
[2, 3]. Although drugs are available clinically for handling
hypercholesterolemia, the consumption of functional foods
or dietary supplements for lowering serum cholesterol and
risk of CVD has gained enormous global acceptance over the
years by the general public [4, 5].
Turtle (Tortoise) jelly, also called gui-ling-gao in Chinese,
is a popular traditional functional food in southern China
and Hong Kong. Traditionally, it is prepared from tortoise
(Chinemys reevesiiGray) shell and various Chinese medicinal
herbs such as Smilacis Glabrae Rhizoma, Millettiae speciosae
Radix, Mesona chinensis Benth, and Lonicerae Japonicae
Flos. Currently, turtle jelly is prepared by more or less
the same herbal components. Since the traditionally use
tortoise species, Chinemys reevesii Gray, is an endangered
species, people use other nonendangered farm grown tor-
toise species, such as Ocadia sinensis, to obtain the tortoise
shell. Turtle jelly is said to possess multiple health-related
beneficial eﬀects such as clearing toxicants from the blood,
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protecting the liver, minimizing the eﬀects of damp-heat,
improving skin disorders and nourishing “yin” [6]. However,
there is no solid evidence for these anecdotal health-benefit
claims.
In our previous study, turtle jelly was demonstrated to
have antioxidant capacity and ability to remove endogenous
free radicals in vitro. In order to further verify the anecdotal
health-benefit claims of turtle jelly in vivo, a study was
launched to investigate the eﬀects of high-cholesterol diet
in rats with or without supplementation of turtle jelly on
the serum lipid profiles [triglycerides, total cholesterol, high-
density lipoprotein (HDL), low-density lipoprotein (LDL)],
levels of fat depositions in liver tissues, and changes in
the activities of key hepatic antioxidative enzymes. Further
investigations on the eﬀects of turtle jelly on endothelium-
dependent vasorelaxation in rat-isolated aortic rings and
the gene and protein expressions of low-density lipopro-
tein receptor (LDLR), phosphoenol pyruvate carboxykinase
(PEPCK), peroxisome proliferation-activated receptors α
(PPAR-α), and 3-hydroxy-3-methyl-glutaryl-CoA reductase
(HMGR) in the livers were carried out so as to understand
themolecular mechanism of turtle jelly in the hepatic system.
2. Materials and Methods
2.1. Preparation of Turtle Jelly Sample Solution and Chemicals.
Turtle jelly was obtained from Hoi Tin Tong Fresh Gui Ling
Gao Company Limited (Hong Kong SAR, China) and it was
stored in dark at 4◦C. The turtle jelly was concentrated by
heating to 100◦C until the volume was reduced to one-eighth
of the original volume. The resultant solution of turtle jelly
was centrifuged (at 625×g, 10min) and filtered. The final
filtrate was used as the testing stock solution. The concentra-
tion of the concentrated turtle jelly solution (stock solution)
was determined by lyophilizing 1mL of the solution in a
freeze drier (Labconco, FreeZone 6). The dry weight of 1mL
concentrated turtle jelly solution was 0.0686 g. Therefore, the
concentration of the concentrated turtle jelly sample solution
was 68.6mg/mL. The tested dosages of turtle jelly were 3.3
and 10mL/kg bw per day, which were equal to 0.23 and
0.69 g/kg bw per day, respectively. The selected dosages of
turtle jelly (3.3 and 10mL/kg bw per day) were equivalent
to one and three times of the recommended human daily
consumption, respectively. Simvastatin 20mg tablets (10%
of tablet weight, content confirmed by HPLC), a positive
control, were purchased from Hangzhou MSD Pharmaceuti-
cal Co., Ltd. Phenylephrine, acetylcholine, indomethacin and
neostigmine were purchased from Sigma Chemicals Co. (St.
Louis, MO, USA). All other chemicals used were of analytical
grade.
2.2. High-Performance Liquid Chromatography (HPLC) Anal-
ysis on Turtle Jelly Sample. Freeze-dried turtle jelly sample
(0.1 g) was accurately weighed and extracted twice with
80% methanol (10mL) for 30min. The extracted solu-
tions were combined and evaporated to dryness with a
rotary evaporator. Before HPLC-DAD analysis, the residue
was redissolved in 80% methanol (5mL) and the sample
solution was filtrated through a syringe filter (0.45 μm).
Chromatographic analysis was carried out on a C18 column
(250mm × 4.6mm, 5 μm) (Alltima, Grace) at 25◦C using
an Agilent 1100 liquid chromatography system equipped
with a quaternary solvent deliver system, an autosampler
and a DAD system. The detection wavelength was 254 nm.
The gradient elution of the mobile phase consisting of (A)
1.0% (v/v) formic acid and (B) methanol is as follows: 90%
(A) at 0min; from 90% to 50% (A) at 0–50min and from
50% to 10% (A) at 50–60min. 10min reequilibrium was
allowed between injections. The flow rate was 1.0mL/min
and aliquots of 10 μL were injected into the HPLC. To
identify components in the turtle sample, an Agilent MSD
Trap VL module mass spectrometer was connected to the
Agilent 1100HPLC instrument via an electrospray ionization
ESI interface. The LC eﬄuent was introduced into the ESI
source in a postcolumn splitting 5 : 1. Ultra high-purity
helium was used as the collision gas, while high-purity
nitrogen was used as the nebulizing gas. The parameters in
the negative/positive ion mode were as follows: the heated
capillary temperature, 350◦C; nebulizer gas, 35 psi, dry gas,
10 L/min. Data acquisition was performed in the full-scan
mode form m/z 100 to 1500 for mass spectrometer and
with an accumulation time of 200ms and 7 microscans were
averaged per recorded scan.
2.3. Animals and Experimental Treatment. Male Sprague-
Dawley rats (170±10 g) were supplied by Guangdong Provin-
cial Medical Laboratory Animal Center (Guangzhou, China).
Rats were housed under standard conditions (temperature
24 ± 2◦C, humidity 60 ± 10%, light from 6 AM to 6 PM)
with free access to water and rat chow. After acclimation for a
week in this laboratory environment, the rats were randomly
assigned to one of the five diﬀerent experimental groups
(each with n = 8). These groups were (1) Control: a control
group fed with normal rat chow obtained from Guangdong
Provincial Medical Laboratory Animal Center (Guangzhou,
China) [composition: protein (∼14%), fat (∼10%), and
carbohydrate (∼76%)]; (2) HCD: a high-cholesterol diet
group fed with high-cholesterol diet, which is a standard rat
chow supplemented with 1% cholic acid, 2% pure cholesterol
and 5.5% oil, as described elsewhere [4, 7]; (3) SIM: a
simvastatin treatment group that received high-cholesterol
diet plus simvastatin (3mg/kg bw per day, p.o.); (4) GL:
a low-dose turtle jelly treatment group that received high-
cholesterol diet plus turtle jelly (3.3mL/kg bw per day,
p.o.); (5) GH: a high-dose turtle jelly treatment group that
received high-cholesterol diet plus turtle jelly (10mL/kg bw
per day, p.o.). The rats were administered with distilled water
(vehicle) or their corresponding treatments by oral gavage
(20mL/kg) once every morning for 30 days. At the end of
the experimental period, the rats were fasted overnight and
killed by cervical dislocation. Blood, livers, and aortas were
then collected for further analysis. The experimental protocol
was conducted under the animal license issued by the Health
Department of the Hong Kong SAR Government and the
Animal Subjects Ethics Sub-committee (ASESC no. 05/21) of
The Hong Kong Polytechnic University. All procedures were
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consistent with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
and the principles outlined in the Declaration of Helsinki.
Every eﬀort was made to limit animal suﬀering and the
number of animals used in this study.
2.4. Analysis of Lipid Levels in Blood Samples. Immediately
after cervical dislocation, blood was collected in chilled
centrifuge tubes by cardiac puncture and allowed to clot for
2 h at 4◦C. The clotted blood was centrifuged (2000×g) at
10◦C for 10min to get the serum. Serumwas stored at−80◦C
until the measuring of lipid profiles. Total serum cholesterol,
triglycerides, LDL, and HDL were measured by the ALYCON
systems using Roche Reagents.
2.5. Liver Histopathological Examination and Lipid Content
Evaluation. Livers obtained from all experimental groups
were first perfused with saline before isolating from the
animals. They were washed immediately with saline, blotted
dry, and weighed. One lobe of each liver sample was then
fixed with 4% paraformaldehyde in 0.1M sodium phosphate
buﬀer (pH 7.4) overnight at 4◦C. After rinsing with water,
the samples were dehydrated and embedded in paraﬃn wax.
Then, the tissue was sectioned to about 5 μm in thickness,
stained with haematoxylin and eosin and examined under
light microscope (400×) and photomicrographs were taken.
Liver samples (each ∼2 g) were dissected and homoge-
nized with 2 : 1 chloroform-methanol mixture (v/v) to a final
dilution of 1 : 20 w/v using Ultra-Turrax T-25 homogenizer.
After filtration, 10mL of individual filtrate was added to
2mL water and the mixture was centrifuged at 900 g for
20min. The lower phase was dried and its weight was
measured [8]. Liver lipid content was expressed as weight of
lipid per g of liver.
2.6. Determination of the Antioxidative Enzyme Activities and
MDA Content in Livers. To monitor the activities of antiox-
idative enzymes in the livers from various experimental
groups, isolated liver (∼1 g) of each rat was weighed and kept
at −80◦C immediately until homogenization procedures.
Each frozen sample was homogenized in ice-cold saline
(1/9, w/v) using an ultra-Turax T-25 homogenizer for 10
bursts of 10 s each, separated by a pause of 15 s. Then,
the homogenates were centrifuged at 10000×g for 5min
(4◦C), and the supernatants were collected and stored at
−20◦C until enzyme activities analysis. Superoxide dis-
mutase (SOD), glutathione peroxidase (GSH-Px), catalase
(CAT), and maleic dialdehyde (MDA) were measured using
commercial kits (Nanjing KeyGen Biotech. Co., Ltd., China).
SOD, GSH-Px, and CAT activities were expressed as U/mg
protein. MDA content was expressed as mmol/mg protein.
The protein content was measured by bicinchoninic acid
(BCA) assay kit (Shenergy Biocolor, Shanghai, China).
2.7. Isolation of Thoracic Aortas. At the end of the treatment
period, the rats were sacrificed and their thoracic aortas
were immediately placed in 4◦C Tyrode’s solution of the
following composition: NaCl 118mM, KCl 4.7mM, KH2PO4
1.2mM, NaHCO3 25mM, glucose 11mM, CaCl2 2.5mM,
and MgSO4 1.2mM. The isolated aorta from each animal
was cut into three ring segments with all fat and connective
tissue removed. One ring from each aortic preparation was
used for endothelium-dependent vasorelaxation (aortic ring,
∼3mm), one for in vitro nitrite production (aortic ring,
∼15mm) and one for real-time PCR analysis of eNOS (aortic
ring ∼15mm).
2.8. Endothelium-Dependent Vasorelaxation of Thoracic Aor-
tas. One of the ring segments was mounted in 5mL organ
bath filled with Tyrode’s solution (37◦C, gassed with 95%
O2 and 5% CO2 mixture) under an optimal load of 1.2 g for
60min. Changes in force were recorded by isometric force-
displacement transducers connected to a PowerLab data
acquisition system, where data sampling rate was set at 40
per minute. The rings were allowed to equilibrate for 60min
under their resting tension (1.2 g). During the equilibration
period, the aortic rings were washed with drug-free Tyrode’s
solution every 20min and the resting tension was readjusted,
whenever necessary, before commencing the experiments.
After the equilibration, the aortic rings were challenged
with 60mM KCl twice to sensitize the preparations. The
contractile response (isometric tension, in g) was measured.
To investigate the relaxant eﬀects of acetylcholine on isolated
aorta, the preparations were precontracted with phenyle-
phrine (1 μM) in the presence of indomethacin (1 μM,
a nonselective cyclooxygenase inhibitor) and neostigmine
(1 μM, an anticholinesterase). After a steady-state contrac-
tion was established, cumulative concentrations (10 nM–
10 μM) of acetylcholine were added to the organ bath.
Concentration-response curves were plotted as percentage
relaxation of phenylephrine-induced contraction against
logarithmic concentration of acetylcholine.
2.9. In Vitro NO Production in the Isolated Thoracic Aortas.
To evaluate the endothelial damage in blood vessels caused
by high-cholesterol diet, in vitro production of nitrite
(NO2
−), which is one of two primary, stable, and nonvolatile
breakdown products of NO, in the aortic ring was tested
to estimate NO production. Briefly, the isolated aortas
were washed twice with Tyrode’s solution and then cut
into 15mm segments (weight = 0.03-0.04 g). The segments
were incubated in a 24-well plate (containing 2mL Tyrode’s
solution per well) with acetylcholine (1 μM) and neostigmine
(1 μM). After incubation (37◦C) for 2 h, each segment was
blotted dry and weighed and the incubated culture solution
of each well was collected in a separate microcentrifuge
tube. The solution of each tube was subsequently dried
by vacuum freeze-drying and the resulting pellets were
redissolved with distilled water (300 μL). Nitrite content was
measured using the Griess reagent system (Promega, USA).
The absorbance was determined using a spectrophotometer
at 540 nm. The concentrations of nitrite were calculated
following instructions of the kit.
2.10. Real-Time Polymerase Chain Reaction Analysis. Isolated
thoracic aortas and livers were homogenized and total
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Table 1: The primer sets used for real-time PCR.
Gene name Forward primer (5′ to 3′) Reverse primer (5′ to 3′) Product size (bp) NCBI reference sequence
eNOS GGATTCTGGCAAGACCGATTAC GGTGAGGACTTGTCCAAACACT 159 NM 021838.2
PEPCK GCGGATACGGTGGGAACTCA TGTCTTCACTGAGGTGCCCG 332 NM 198780.3
LDLR TGGCTATGAGTGCCTATGTC GGTGAAGAGCAGAAACCCTA 211 NM 175762
PPARα GCCGTTTCCACAAGTGCC GCTAGTCTTTCCTGCGAGTATG 236 NM 013196.1
HMGR CAACATCGTCACTGCCATC GATGCTCAAGCTGCCTTCTT 411 X55286
GAPDH TGCACCACCAACTGCTTAG AGTGGATGCAGGGATGATGT 180 NM 017008
Table 2: Serum lipid levels of rats in various groups.
Animals groups Control (n = 5) HCD (n = 5) SIM (n = 7) GL (n = 5) GH (n = 5)
Total cholesterol (mmol/L) 2.30 ± 0.13 10.33 ± 1.05### 6.10 ± 0.81#,∗ 7.40 ± 1.12## 6.95 ± 0.65##,∗
Triglyceride (mmol/L) 3.26 ± 0.52 3.29 ± 0.29 2.26 ± 0.50 2.40 ± 0.46 2.98 ± 0.36
LDL (mmol/L) 0.52 ± 0.02 3.68 ± 0.37### 1.92 ± 0.26##,∗∗ 2.45 ± 0.43###,∗ 2.46 ± 0.28###,∗
HDL (mmol/L) 1.37 ± 0.11 1.74 ± 0.04 1.58 ± 0.12 1.66 ± 0.13 1.69 ± 0.13
LDL/HDL 0.39 ± 0.04 2.11 ± 0.20### 1.22 ± 0.13###,∗∗∗ 1.44 ± 0.18###,∗ 1.45 ± 0.10###,∗
Data are expressed as means ± SEM, (n = 5–7).
#P < 0.05, ##P < 0.01, and ###P < 0.001 represent significant diﬀerences when compared with the control group.
∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 represent significant diﬀerences when compared with the HCD group.
RNA was extracted using Trizol reagent (Invitrogen) for
the determination of gene expression levels of aortic eNOS
and hepatic PEPCK, LDLR, PPARα, and HMGR in various
groups. 2.0 μg of total RNA was reverse transcribed into
cDNA using RevertAid first-strand cDNA synthesis kit
(Fermentas). Real-time PCR was performed with iQ SYBR
Green Supermix (Bio-Rad) in 20 μL of total reactionmixture.
The primers for eNOS, PEPCK, LDLR, PPARα, HMGR,
and GAPDH were synthesized by Shanghai GeneCore Bio
Technologies Co. Ltd. (China) (Table 1). Each real-time RT-
PCR reaction was performed in triplicate and a standard
curve was generated each time for assessing the expression
level in cDNA. To correct for diﬀerences in quantity and
quality between diﬀerent RNA samples, the expression levels
of various mRNA of interest were expressed as the ratios
of mRNA expression of individual gene to that of the
housekeeping gene, GAPDH, in the corresponding samples.
2.11. Western Blot Immunoreactivity Assay. Hepatic LDLR,
PEPCK, PPARα, and HMGR protein levels were quantified
using immunoblotting procedures. Protein extracts (5 μg for
PEPCK and GAPDH, 20 μg for LDLR and HMGR, 40 μg
for PPARα) were applied to 12% SDS polyacrylamide gels
and transferred to polyvinylidene difluoride membranes,
which were blotted overnight at 4◦C with nonfat dry
milk solution. Blots were incubated with the appropriate
antibody (Abcam Inc., USA) for 2 h at room temperature.
The membrane was subsequently probed with a secondary
goat anti-rabbit or goat anti-mouse IgG conjugated to
horseradish peroxidase for 1 h at room temperature at a
dilution of 1 : 5000 and 1 : 10000, respectively (Kangchen
Bio-tech, Shanghai, China). Immunoreactive bands were
visualized by Immun-Star WesternC Chemiluminescent Kit
in a ChemiDoc XRS machine and analyzed using Quantity
One 4.6.7 for Windows (Bio-Rad, U.S.A.) software. Each
reported value was derived from the ratio between arbitrary
units obtained by protein band and the respective GAPDH
band (36 kDa, chosen as housekeeping protein).
2.12. Statistical Analysis. Data were expressed as means ±
SEM and n denotes the number of replications for each data
point. After validation of each parameter for homogeneity of
variance, intergroup diﬀerences were analyzed by using one-
way analysis of variance (ANOVA) and Dunnett’s multiple
comparison test as posttest after ANOVA was performed
to compare the group means by the statistical software,
GraphPad Prism 5.02 (San Diego, CA, USA) for Windows.
A value of probability (P) < 0.05 was considered statistically
significant.
3. Results
3.1. HPLC Fingerprint. A representative HPLC chromato-
gram was shown in Figure 1. Totally, nine peaks were iden-
tified from the sample by the mass spectrometer. Their iden-
tities and relative content (in terms of peak area under the
254 nm detection wavelength) in the freeze-dried GLG sam-
ple were caﬀeoylquinic acid (1.04%), 5-O-caﬀeoylshikimic
acid (5.44%), astilbin (2.66%), 3,4-dicaﬀeoylquinic acid
(2.02%), 4,5-dicaﬀeoylquinic acid (1.66%), neoisoastilbin
(3.01%), isoastilbin (3.61%), engeletin (1.07%), and 3,5-
dicafeoyylquinic acid (1.61%).
3.2. Eﬀects on Serum Lipids Profiles. The lipid profiles: serum
total cholesterol, triglycerides, HDL, and LDL from various
rat groups are summarized in Table 2. A high-cholesterol
diet significantly upregulated total cholesterol and LDL
content in serum (both, P < 0.001). The serum total
cholesterol was significantly reduced in the SIM (6.10 ±
0.81mmol/L, P < 0.05), GH group (6.95 ± 0.65mmol/L,
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Figure 1: HPLC/UV (254 nm) chromatogram of the turtle jelly
sample used in the current study. (1) caﬀeoylquinic acid, (2) 5-
O-caﬀeoylshikimic acid, (3) astilbin, (4) 3,4-dicaﬀeoylquinic acid,
(5) 4,5-dicaﬀeoylquinic acid, (6) neoisoastilbin, (7) isoastilbin, (8)
engeletin, and (9) 3,5-dicafeoyylquinic acid.
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Figure 2: The atherogenic indexes of animals from the groups
of Control, HCD, SIM (3mg/kg bw per day), GL (3.3mL/kg bw
per day), and GH (10mL/kg bw per day). Data are expressed as
means ± SEM, n = 5–7. ##P < 0.01 and ###P < 0.001 represent
significant diﬀerences when compared with the Control. ∗P < 0.05
and ∗∗P < 0.01 represent significant diﬀerences when compared
with the HCD. The number in parentheses is n for individual group.
P < 0.05) as compared with that in the HCD group (10.33±
1.05mmol/L). Animals treated with simvastatin (3mg/kg
bw per day) (1.92 ± 0.26mmol/L, P < 0.01) or turtle
jelly (3.3mL/kg bw per day: 2.45 ± 0.43mmol/L, P < 0.05
or 10mL/kg bw per day: 2.46 ± 0.28mmol/L, P < 0.05)
could significantly reduce serum LDL as compared with
the HCD group (3.68 ± 0.37mmol/L). However, both total
cholesterol and LDL content in serum did not return to
normal (control) level (total cholesterol: 2.30±0.13mmol/L;
LDL: 0.52 ± 0.02mmol/L) in all treatment groups. Animals
with high-cholesterol diet showed no significant changes in
the level of triglycerides (P > 0.05) or HDL (P > 0.05).
Further analysis of the impact of serum lipid profiles on
the progression of atherosclerosis, the atherogenic index
[(total serum cholesterol − HDL)/HDL] (which measures
coronary heart disease risk), was calculated. It was found
that elevated atherogenic index was observed in the HCD
group (Figure 2). Consumption of turtle jelly could signifi-
cantly decrease the atherogenic indexes in a dose-dependent
manner (GL: P < 0.05; GH: P < 0.01). Turtle jelly showed
an eﬀect comparable to simvastatin on lowering elevated
atherogenic index, suggesting that both simvastatin and
turtle jelly possess atheroscleroprotective potential in the
current experimental setting.
3.3. Determination of the Antioxidative Enzyme Activities and
MDA Content in Livers. Figure 3 depicts the activities of
antioxidant enzymes: CAT, SOD, and GSH-Px in the livers
of rats from the Control, HCD, SIM, GL, and GH groups.
There was a marked decrease in CAT (P < 0.01), SOD
(P < 0.01), and GSH-Px (P < 0.05) activities in the HCD
group as compared with the control rats. For the activity of
CAT, treating the animals with simvastatin (P < 0.05) or
turtle jelly (3.3mL/kg bw per day only, P < 0.01) managed to
restore the high-cholesterol diet-induced reduction of CAT
activity (Figure 3(a)). No significant changes (P > 0.05) in
SOD activities were found amongst the HCD, SIM, GL, and
GH groups as compared with the HDC group (Figure 3(b)).
Comparing with the HCD rats, treating the animals with
turtle jelly, but not simvastatin, could significantly raise the
liver GSH-Px activity in a dose-dependent manner (P < 0.01,
Figure 3(c)). A marked increase of MDA content in the HCD
group was recorded as compared with the control rats (P <
0.001, Figure 3(d)). Treating the animals with simvastatin
(P < 0.01) or turtle jelly (both 3.3 and 10mL/kg bw per
day, P < 0.001) significantly decreased the MDA content as
compared with the HCD rats (Figure 3(d)).
3.4. Liver Histological Examination and Lipid Content Eval-
uation. The gross appearances of the livers from rats fed
with normal diet, high-cholesterol diet, high-cholesterol diet
plus simvastatin or two diﬀerent dosages of turtle jelly are
depicted in Figure 4. The livers of the control (normal) rats
had a relatively dark-red colour whereas those from the
HCD group were enlarged with a yellowish colour. Treating
the rats with simvastatin or turtle jelly could make the
colour of liver relatively “less yellowish” as was observed in
the HCD rats (Figures 4(c)–4(e)). Histological examination
of the livers of the control rats revealed intact cellular
structure (Figure 4(a)). In contrast, the livers of rats from
the HCD group illustrated poor cellularity with extensive
lipid depositions and enlarged hepatocytes (Figure 4(b)). In
animals administrated with simvastatin or turtle jelly, a lesser
degree of lipid deposition and hepatocytes enlargement was
observed (Figures 4(c)–4(e)).
In order to evaluate the lipid content in the livers from
diﬀerent treatment groups, (i) liver index (weight of liver
(g) to animal’s body weight (kg)) and (ii) total lipid in
the liver was measured and compared (Figure 5). There
were significant increases in both liver index (P < 0.001)
and liver lipid content (P < 0.001) in the HCD group as
compared with those in the Control group. Interestingly,
supplementing the animals with 3.3 or 10mL/kg bw per day
of turtle jelly could dose-dependently reduce the increased
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Figure 3: (a) CAT, (b) SOD, (c) GSH-PX activities, and (d) MDA contents of isolated livers from the Control, HCD, SIM (3mg/kg bw per
day), GL (3.3mL/kg bw per day), and GH (10mL/kg bw per day). Data are expressed as means ± SEM, n = 5–8. #P < 0.05, ##P < 0.01,
and ###P < 0.001 represent significant diﬀerences when compared with the Control. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001 represent
significant diﬀerences when compared with the HCD. The number in parentheses is n for individual group.
liver index and lipid content of hypercholesterolemic rats
(Figures 5(a) and 5(b)). This suggested the hepatoprotective
eﬀect of turtle jelly in the current experimental setting.
Simvastatin exhibited hepatoprotective eﬀect similar to turtle
jelly.
3.5. Measurement of the Isometric Tension of the Isolated
Thoracic Aortas. To evaluate the protective eﬀect of turtle
jelly administration on vascular endothelial activity, the
thoracic aorta (with intact endothelium) was isolated for
isometric tension analyses. When phenylephrine (1 μM)-
induced contraction reached a steady condition, acetyl-
choline was added cumulatively to the aortic preparation in
the presence of neostigmine (1 μM). Acetylcholine elicited
a concentration (10 nM–10 μM)-dependent aortic relax-
ation of various groups of rats with ∼45–75% maximum
relaxation at 10 μM (n = 8) (Figure 6). A significantly
smaller magnitude of relaxation caused by acetylcholine was
observed in aortas from HCD rats as compared with those
observed in other groups (P < 0.01) (Figure 6). Turtle jelly
(3.3 or 10mL/kg bw per day, P < 0.05) dose-dependently
improved the acetylcholine-induced relaxation in rats with
high-cholesterol diet. Ameliorations in the acetylcholine-
induced relaxation were only observed in animals treated
with simvastatin (3mg/kg bw per day) or higher dose of
turtle jelly (10mL/kg bw per day) (Figure 6).
3.6. In Vitro Nitrite Production and eNOS mRNA Expression
Level in the Isolated Thoracic Aortas. The eﬀect of turtle
jelly treatment on high-cholesterol diet-induced damage on
aortic endothelial cells was also evaluated. The isolated aortic
rings from various groups were tested with regard to their
nitrite production ability. Without acetylcholine (1 μM),
aortic rings released undetectable levels of nitrite after 2 h
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Figure 4: Histological examination of the livers obtained from the (a) Control, (b) HCD, (c) SIM (3mg/kg bw per day), (d) GL (3.3mL/kg
bw per day), and (e) GH (10mL/kg bw per day). Photographs of the cross-section (400× magnification) of livers (top) and the gross
appearance of the entire livers (bottom) are illustrated. Arrows show the location of lipid depositions.
of incubation (data not shown). When acetylcholine (1 μM)
was added to the incubation medium, nitrite production
in the Control group increased dramatically to 1.04 ±
0.19mmol/g of aortic tissue after the 2 h incubation period.
The eﬀect of acetylcholine on nitrite production could be
abolished by the NOS inhibitor L-NAME (20 μM) (data not
shown). It was found that high-cholesterol diet markedly
attenuated nitrite production (0.29 ± 0.18mmol/g of aortic
tissue, P < 0.05). As shown in Figure 7(a), aortas from
the simvastatin (3mg/kg bw per day) treatment group
significantly potentiated nitrite production and completely
restored the HCD-induced vascular damage. There was a
slight and insignificant increase in the turtle jelly treatment
groups (both dosages) as compared with the HCD group
(P > 0.05) (Figure 7(a)).
Apart from estimating NO production (using nitrite
production), changes in the mRNA expression of eNOS in
aortas were also examined by quantitative real-time RT-
PCR (Figure 7(b)). The mRNA expression level of eNOS in
the aortas from the HCD group was markedly suppressed
(P < 0.05); whereas treatment of simvastatin (3mg/kg
bw per day) could significantly increase eNOS expression
8 Evidence-Based Complementary and Alternative Medicine
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Figure 5: (a) Liver indexes (g of liver per kg bw) for various groups. (b) Total lipid contents (g of lipid per g of liver) isolated from various
groups. Data are expressed as means ± SEM, n = 8. ###P < 0.001 represents significant diﬀerences when compared with the Control.
∗∗P < 0.01 when compared with the HCD group.∗P < 0.05 and ∗∗P < 0.01 represent significant diﬀerences when compared with the HCD.
The number in parentheses is n for individual group.
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Figure 6: The concentration-response curves to acetylcholine are
expressed as decrease in (percentage) steady-state tension obtained
with 1 μM phenylephrine precontracted thoracic aortic rings from
the Control, HCD, SIM (3mg/kg bw per day), GL (3.3mL/kg bw
per day), and GH (10mL/kg bw per day). Data are expressed as
means ± SEM, n = 8. #P < 0.05 ##P < 0.01, and ###P < 0.001
represent significant diﬀerences when compared with the Control.
∗P < 0.05 represents significant diﬀerences when compared with
the HCD. The number in parentheses is n for individual group.
level back to the level in the Control group (P < 0.05).
Animals treated with turtle jelly (3.3 or 10mL/kg bw per day)
showed a slight and insignificant enhancement in the gene
expression of eNOS (P > 0.05). The pattern of eNOS mRNA
expressions observed amongst diﬀerent groups was similar
to the pattern of nitrite productions amongst the diﬀerent
groups (Figure 7).
3.7. Eﬀects of Turtle Jelly on Gene and Protein Expressions of
LDLR, PEPCK, PPARα, and HMGR in the Livers. Changes
in the mRNA and protein expressions of LDLR, PEPCK,
PPARα, and HMG in the livers are shown in Figures 8 and
9. High-cholesterol diet could markedly suppress the gene
and protein expression levels of LDLR (both expressions
with P < 0.05, Figures 8(a) and 9(a)), PEPCK (both
expressions with P < 0.05, Figures 8(b) and 9(b)) and
HMGR (gene expression with P < 0.01, Figure 8(d); protein
expression with P < 0.05, Figure 9(d)) but promote those
of PPARα (gene with P < 0.001, Figure 8(c); protein with
P < 0.05, Figure 9(c)) in the livers as compared with their
corresponding controls. Simvastatin (3mg/kg bw per day)
significantly restored (P < 0.05) the high-cholesterol diet-
induced downregulations of LDLR and PEPCK mRNA and
protein back to a level close to their normal conditions. The
liver PPARα mRNA (P < 0.01) and protein (P < 0.05)
expressions were markedly suppressed in animals from the
SIM group as compared with the HCD groups. Adminis-
tration of turtle jelly led to a dose-dependent restoration
of the mRNA and protein expressions of LDLR, PEPCK,
and PPARα in the livers (Figures 8 and 9). High dosage
of turtle jelly (10mL/kg bw per day) significantly reversed
the high-cholesterol diet-induced changes in the mRNA and
protein expressions of LDLR (both expressions with P <
0.05, Figures 8(a) and 9(a)), PEPCK (gene expression with
P < 0.01, Figure 8(b); protein expression with P < 0.05,
Figure 9(b)) and PPARα (gene expression with P < 0.01,
Figure 8(c); protein expression with P < 0.05, Figure 9(c))
in the livers as compared with their corresponding HCD
groups. Both simvastatin and turtle jelly had no significant
(P > 0.05) eﬀects on the altering of the gene and protein
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Figure 7: (a) In vitro nitrite productions from various groups’ isolated aortas under challenge with acetylcholine (1 μM) and (b) eNOS
mRNA expressions in various groups’ isolated aortas. The expression level of eNOSwas normalized to that of the GAPDH. Data are expressed
as means ± SEM, n = 4–6. #P < 0.05 represents significant diﬀerences when compared with the Control. ∗P < 0.05 represents significant
diﬀerences when compared with the HCD. The number in parentheses is n for individual group.
expressions of HMGR as compared with the HCD animals
(Figures 8(d) and 9(d)).
4. Discussion
Diet plays an important role in the regulation of choles-
terol homeostasis. In recent decades, functional food and
natural dietary substances have been extensively studied to
determine their role in preventing CVD [4, 7, 9]. In fact,
hypercholesterolemic condition is regarded as an important
factor in the development of CVD [10]. Therefore, natural
products or functional foods with hypolipidemic and/or
hypocholesterolemic eﬀects are believed to be useful in
reducing the risk of developing CVD [4]. In the present
study, it has been demonstrated for the first time that high-
cholesterol-induced complications such as increased lipid
levels, fatty liver as well as endothelial dysfunction can
be dose-dependently normalized by oral administration of
turtle jelly at the dosage of 3.3 or 10mL/kg bw per day
for 30 days. The overall beneficial eﬀects provided by high
dosage of turtle jelly were better than those given by low
dosage of turtle jelly. Although the eﬀect of turtle jelly was
not as good as simvastatin, a potent hypocholesterolemic and
hypolipidemic drug, turtle jelly is still a good alternative to
counteract the detrimental eﬀects brought about by high-
cholesterol diet.
In the current study, the animals in the HCD group had
abnormal serum lipid levels with significantly increased total
cholesterol and LDL but no significant changes in triglyceride
and HDL levels. These results are consistent with our
pervious studies with similar experimental settings [7, 9].
The degree of elevation in serum total cholesterol and LDL
levels is considerable enough to induce the atherogenic eﬀect
of the current model since both parameters play a major role
in atherosclerosis development and the subsequent coronary
heart disease [11]. We demonstrated that administration
of turtle jelly significantly reduced serum total cholesterol
(P < 0.05), LDL (P < 0.05), and LDL/HDL ratio (P <
0.05) in rats fed with high-cholesterol diet. The eﬀects of
high dosage of turtle jelly on the lipid profile were close to
those given by simvastatin (3mg/kg bw per day), a potent
drug of statin series (such as lovastatin, fluvastatin, and
pravastatin). Additionally, the elevated atherogenic index
induced by high-cholesterol diet was suppressed significantly
by turtle jelly. This suggested that turtle jelly consumption
could provide atheroscleroprotective eﬀect to the body.
The liver is the primary organ to metabolize the
cholesterol ingested. In the present study, extensive fat
depositions were observed in the liver of rats fed with high-
cholesterol diet alone. Histological examination showed that
animals from the HCD group had enlarged livers (with
higher liver index), accumulation of lipid depositions and
overall lipid contents in the livers, loss of hepatocytes
integrity, and hepatocytes enlargement. These changes are
probably associated with or responsible for the aberrant
changes of cholesterol/lipoprotein observed (i.e., fatty liver)
in hypercholesterolemic rats. Turtle jelly is said to be capable
of clearing toxicants from the blood, protecting the liver,
and minimizing the eﬀects of damp-heat [6]. The eﬀects
of turtle jelly on lowering serum cholesterol in blood and
reducing lipid deposition in the liver could be interpreted
as clearing toxicants from the blood and protecting the
liver, respectively. Therefore, the current findings could be
considered as strong scientific evidence for the anecdotal
health benefit claims of consuming turtle jelly.
Hypercholesterolemic diet could aﬀect the functions of
liver substantially because of the high-cholesterol condition
10 Evidence-Based Complementary and Alternative Medicine
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Figure 8: Real-time RT-PCR analysis of the mRNA expressions of (a) LDLR, (b) PEPCK, (c) PPARα, and (d) HMGR in the livers from the
Control, HCD, SIM (3mg/kg bw per day), GL (3.3mL/kg bw per day), and GH (10mL/kg bw per day). The expression level of each gene was
normalized to that of the GAPDH gene in each sample. Data are expressed as means ± SEM, n = 4–7. #P < 0.05, ##P < 0.01, and ##P < 0.01
represent significant diﬀerences when compared with the Control group. ∗P < 0.05 and ∗∗P < 0.01 represent significant diﬀerences when
compared with the HCD. The number in parentheses is n for individual group.
that causes an excessive production of reactive oxygen species
(ROS), which in turn could initiate lipid peroxidation, dam-
age liver functions, and aﬀect the cardiovascular system [12–
14]. Therefore, controlling the production of endogenous
prooxidant levels in liver cells is important to prevent the
development of CVD such as atherosclerosis [4, 15, 16]. Liver
contains enzymes such as CAT, SOD, and GSH-Px which
contribute to the antioxidant defense mechanisms [17].
Studies have shown that hypercholesterolemia diminishes
the eﬀectiveness of the antioxidant defense system and
decreases the activities of CAT and SOD in rats [18, 19].
In the current experimental settings, decreases in CAT,
SOD, and GSH-Px activities were observed in hypercholes-
terolemic rats as compared with those of the Control group.
Administration of turtle jelly for 30 days to rats fed with
high-cholesterol diet significantly elevated the activities of
CAT and GSH-Px, but not the activity of SOD, in the liver.
The mechanism for upregulation of CAT- and GSH-Px-
specific enzyme activity induced by turtle jelly is current
unknown and warrants further studies.
MDA, the product of lipid peroxidation, is an estimator
of oxygen-free radical level. A decrease in lipid peroxi-
dation leads to a reduction of atherosclerosis caused by
hypercholesterolemia [20]. The content of MDA in rats
fed with high-cholesterol diet was raised compared with
the control animals, suggesting that hypercholesterolemia
could enhance the process of lipid peroxidation. The oral
administration of simvastatin or turtle jelly prevented a high-
cholesterol diet-induced elevation of MDA and resulted in a
significant decreased MDA content in the liver. These data
suggested that turtle jelly could improve the eﬃciency of
H2O2 reduction into H2O due to the increased GSH-Px
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Figure 9: Representative Western blots and graphs represent quantitative comparisons of protein expressions of (a) LDLR, (b) PEPCK, (c)
PPARα, and (d) HMGR in the livers from the Control, HCD, SIM (3mg/kg bw per day), GL (3.3mL/kg bw per day), and GH (10mL/kg
bw per day). The expression level of each protein was normalized to that of the GAPDH protein in each sample. Data are expressed as
means ± SEM, n = 4–7. #P < 0.05 represents significant diﬀerences when compared with the Control. ∗P < 0.05 represents significant
diﬀerences when compared with the HCD. The number in parentheses is n for individual group.
and/or CAT activities as well as lower or slow down oxidative-
stress-related lipid peroxidation.
Hypercholesterolemia and atherosclerosis are closely
related to vascular dysfunction [21] because under hyperc-
holesterolemic condition, endothelial production of super-
oxide, and possibly other ROS, increases and quenches
NO [22]. NO is derived from endothelium which plays
an important role in the homeostasis of vascular tone and
structure under normal circumstances [23]. In the current
study, a blunted acetylcholine-induced vascular relaxation
which represents an endothelial/NO dysfunction was found
in the aortas isolated from the HCD group. This is consistent
with previous reports that described in animals [7, 24] and
humans [25]. Simvastatin improved acetylcholine-induced
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relaxation on isolated aortic rings, an improvement that can
be explained by the upregulation of eNOS mRNA expression
and/or increase in acetylcholine-induced nitrite production
(represented an increase in NO production) that counteract
NO inactivation under hypercholesterolemic condition. It
was found that the consumption of turtle jelly for 30 days by
hypercholesterolemic rats could dose-dependently prevent
endothelial/NO dysfunction with slight (but statistically
insignificant) enhancements in both eNOS gene expression
and NO production. The observed statistically insignificant
phenomenon might be due to the limited sample size and/or
short treatment period. Further studies with increased
number of animals per group and/or longer treatment period
could, undoubtedly, help give a conclusive explanation on
the mechanistic pathway of turtle jelly in the prevention
of endothelial dysfunction induced by hypercholesterolemic
diet.
The eﬀects of turtle jelly on the expressions of LDLR,
PEPCK, PPARα, and HMGR mRNA and proteins in the
liver were also under investigation in hypercholesterolemic
animals treated with turtle jelly. The liver is the most
important site for cholesterol metabolism. HMGR is an
enzyme responsible for cholesterol synthesis. It is believed
that HMGR is regulated through negative feedback of
cholesterol [9]. Low cholesterol level would trigger HMGR
transcription so as to enhance cholesterol synthesis. In this
study, suppressed mRNA and protein expressions of HMGR
were observed in the HCD, SIM, GL, and GH groups.
There were no significant diﬀerences in HMGR (mRNA
and protein) expressions amongst the four groups of high-
cholesterol diet-fed animals. Hence the hypocholesterolemic
eﬀect exerted by turtle jelly may not be related to the
inhibition of cholesterol synthesis.
LDL (the “bad” cholesterol) is closely associated with
CVD. The LDLR pathway mediates at least 60–75% of
LDL turnover in rats [26, 27] and 56–80% in humans
[26, 28]. Since the liver contains about 70% of total LDLR
present in the body [29], changes in serum LDL levels are
generally due to changes in hepatic LDLR activity. In this
study, hepatic LDLR expression was investigated. We found
that hypercholesterolemic diet caused a significant reduction
in hepatic LDLR mRNA and protein expression levels.
Simvastatin (3mg/kg bw per day) and turtle jelly (10mL/kg
bw per day) could significantly upregulate both LDLRmRNA
and protein expressions, which in turn reduced the serum
LDL level. In fact, similar observations about simvastatin
treatment on LDLR had been reported in other studies [30–
32], but this report is the first about the upregulation of both
LDLR mRNA and protein expressions by turtle jelly. It is
interesting to note that hepatic LDLR mRNA and protein
expressions were only enhanced significantly in animals in
the SIM and GH groups, (but not GL); whiles all three
treatment groups (SIM, GL, and GH) could markedly lower
serum LDL. This mismatch might indicate that turtle jelly
could provide LDL-lowering eﬀect through more than one
pathway. High dosage of turtle jelly (10mL/kg bw per day)
predominately adopted upregulating LDLR to facilitate its
LDL-lowering eﬀect, but low dosage of turtle jelly (3.3mL/kg
bw per day) did not. Confirmatory studies on other animal
models are warranted. In order to explore the mechanism(s)
of turtle jelly on lowering serum cholesterol and LDL, further
studies that include the monitoring on fecal lipid or fecal bile
acid excretion are warranted.
PEPCK is a rate-limiting enzyme in renal and hepatic
gluconeogenesis. Hepatic PEPCK plays a crucial role in
modulating lipid homeostasis and is regulated by a variety
of dietary and hormonal signals [33]. Liver-specific PEPCK
knockout mice exhibit impaired lipid metabolism and
develop hepatic steatosis apparently because glyceroneogen-
esis is an important function of PEPCK in hepatocytes [34,
35]. In this study, the PEPCK gene and protein expression
levels were significantly decreased in the HCD group, which
showed obvious fatty and enlarged liver, accumulation of
lipid deposition around hepatocyes and increase in overall
hepatic lipid content as compared with those of the Control
group. Similar results had been reported by others [36].
Treating hypercholesterolemic rats with turtle jelly markedly
elevated PEPCK gene and protein expressions as compared
with the Control group. Turtle jelly could promote the
generation of glucose from noncarbohydrate carbon sub-
strates such as glycerol from lipid by regulating the PEPCK
pathway. Therefore, it could signal the body to use more
lipid and/or cholesterol as the energy source so as to give its
hypocholesterolemic eﬀect.
To further understand the role of turtle jelly in lipid
homeostasis, the mRNA and protein expressions of PPARα
were also investigated. PPARα, a ligand-activated transcrip-
tion factor, is primarily expressed in the liver and is known
to promote the β-oxidation of fatty acids and play a pivotal
role in the regulation of lipid homeostasis [37, 38]. It
has been shown that mice lacking PPARα exhibit hepatic
steatosis, hypoglycemia, and myocardial lipid accumulation
[39]. PPARα mRNA expression was positively correlated
with dietary fat intake in rat as an increased supply of
fatty acids, endogenous ligand for PPARα receptor, might
contribute to an increased PPARα signaling and upregulated
PPARα mRNA expression [40]. This can explain why
agonists of PPARα have atheroscleroprotective eﬀects. In
the current experimental condition, animals in the HCD
group showed an upregulation of PPARαmRNA and protein
expressions. This might be due to the extra 5.5% oil in
the diet which provided more fatty acids to stimulate
PPARα receptors in the liver. The amelioration of the
upregulated PPARα gene and protein expressions induced by
hypercholesterolemic diet was achieved in animals treated
with simvastatin or turtle jelly (10mL/kg bw per day).
Simvastatin and turtle jelly may have direct eﬀect on the
PPARαmRNA and protein expressions in the liver. However,
the possibility that the observed downregulation of PPARα
mRNA and protein expressions in the treatment groups is
solely due to the hypocholesterolemic eﬀect through other
physiological pathways cannot be ruled out. A study of
the role of turtle jelly in the PPARα signaling pathway
is being carried out in our laboratory to explain the
hypocholesterolemic and hepatoprotective eﬀects of turtle
jelly.
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5. Conclusions
The present results demonstrated for the first time that
consumption of turtle jelly for 30 days has significant
hypocholesterolemic eﬀect in terms of reducing the plasma
total cholesterol and LDL and alleviating the plasma HDL
in rats fed with high-cholesterol diet. For the prominent
improvements on atherogenic index after treating hyperc-
holesterolemic rats with turtle jelly, turtle jelly was suggested
to possess antiatherogenic capacity. In addition, turtle jelly
administration could demonstrate good hepatoprotective
function in terms of reducing fat depositions and overall
lipid contents in the liver, increasing the activities of hepatic
antioxidative enzymes such as GSH-Px and CAT activities
and lowering oxidative-stress-related lipid peroxidation. The
blunted NO/endothelium-mediated aortic relaxation in rats
fed with high-cholesterol diet was restored to a certain
extent after turtle jelly consumption. It is postulated that
hypocholesterolemic eﬀect is the primary beneficial eﬀect
given by turtle jelly and it leads to other secondary ben-
eficial eﬀects such as vasoprotective and hepatoprotective
functions. The present data suggest that turtle jelly could
block the downregulation of LDLR and PEPCK mRNA and
protein expressions as well as suppress the upregulation of
PPARαmRNA and protein expressions in the livers in rats fed
with high-cholesterol diet. Although the precise molecular
mechanism exerted by turtle jelly on regulating lipid and
cholesterol metabolisms is currently unknown, the present
study provides clear scientific evidence to prove the anecdotal
health-benefit claims that the consumption of turtle jelly as a
functional food could clear toxicants (such as cholesterol and
LDL) from the blood and protect the liver. Further studies on
other animal models as well as other cholesterol metabolism
mechanisms would provide in-depth understanding of the
hypocholesterolemic eﬀects of turtle jelly.
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